Myomo Inc. (MYO)
Bid | 5.1 |
Market Cap | 182.22M |
Revenue (ttm) | 27.82M |
Net Income (ttm) | -5.28M |
EPS (ttm) | -0.16 |
PE Ratio (ttm) | -33.12 |
Forward PE | -71.51 |
Analyst | Strong Buy |
Ask | 5.6 |
Volume | 522,742 |
Avg. Volume (20D) | 467,529 |
Open | 5.29 |
Previous Close | 5.44 |
Day's Range | 5.17 - 5.38 |
52-Week Range | 2.51 - 7.17 |
Beta | 1.60 |
About MYO
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to help improve function in adults and adolescents wit...
Analyst Forecast
According to 4 analyst ratings, the average rating for MYO stock is "Strong Buy." The 12-month stock price forecast is $10.25, which is an increase of 93.40% from the latest price.
Stock ForecastsEarnings Surprise
Next Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription

2 weeks ago · businesswire.com
Myomo to Report Fourth Quarter 2024 Financial Results on March 10BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurol...